Related Experiment Videos
Receptor binding studies on A1-(2-nitro-4-trimethylammoniophenyl)insulin
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie
|March 1, 1979
Summary
A novel insulin derivative, A1-(2-nitro-4-trimethylammoniophenyl)insulin, demonstrates insulin-like properties in receptor binding and fat cell assays. This suggests a charged group at A1-glycine is crucial for insulin activity.
Area of Science:
- Biochemistry
- Pharmacology
- Endocrinology
Background:
- Insulin is a key hormone regulating glucose metabolism.
- Modifications to insulin structure can alter its activity and therapeutic potential.
Purpose of the Study:
- To evaluate the biological activity of a novel insulin derivative, A1-(2-nitro-4-trimethylammoniophenyl)insulin.
- To investigate the role of a charged moiety at the A1-glycine position in insulin's function.
Main Methods:
- Receptor binding studies were performed to assess the affinity of the insulin derivative.
- Isolated fat cell assays were utilized to measure the biological potency of the derivative.
Main Results:
- The A1-(2-nitro-4-trimethylammoniophenyl)insulin derivative exhibited properties comparable to native insulin in receptor binding assays.
- Fat cell assays indicated a potency of 76 +/- 4% relative to native insulin.
Conclusions:
- A charged, hydrophilic group attached at the A1-glycine position is important for maintaining insulin's biological activity.
- This finding has implications for the design of modified insulins with altered pharmacokinetic or pharmacodynamic profiles.